Background: PCR with sequence-specific priming using allele-specific fluorescent primers and analysis on a capillary sequencer is a standard technique for DNA typing. We aimed to adapt this method for donor typing in a medium-throughput setting. Methods: Using the Extract-N-Amp PCR system, we devised a set of eight multiplex allele-specific PCR with fluorescent primers for Fya/Fyb, Jka/Jkb, M/N, and S/s. The alleles of a gene were discriminated by the fluorescent color; donor and polymorphism investigated were encoded by product length. Time, cost, and routine performance were collated. Discrepant samples were investigated by sequencing. The association of new alleles with the phenotype was evaluated by a step-wise statistical analysis. Results: On validation using 312 samples, for 1.1% of antigens (in 5.4% of samples) no prediction was obtained. 99.96% of predictions were correct. Consumable cost per donor were below EUR 2.00. In routine use, 92.2% of samples were successfully predicted. Discrepancies were most frequently due to technical reasons. A total of 11 previously unknown alleles were detected in the Kell, Lutheran, and Colton blood group systems. In 2017, more than 20% of the RBC units prepared by our institution were from donors with predicted antigen status. A steady supply of Yt(a-), Co(a-) and Lu(b-) RBC units was ensured. Conclusions: Pooled capillary electrophoresis offers a suitable alternative to other methods for extended donor DNA typing. Establishing a large cohort of typed donors improved transfusion support for patients.

Keywords:
Blood donor typing, Colton blood group, Immunohematology, Kell blood group, Lutheran blood group, Molecular blood group typing, Null allele
1.
Flegel WA, Gottschall JL, Denomme GA: Integration of red cell genotyping into the blood supply chain: a population-based study. Lancet Haematol 2015;2:e282-e288.
2.
Flegel WA, Gottschall JL, Denomme GA: Implementing mass-scale red cell genotyping at a blood center. Transfusion 2015;55:2610-2615; quiz 2609.
3.
Avent ND, Martinez A, Flegel WA, Olsson ML, Scott ML, Nogues N, Pisacka M, Daniels GL, Muniz-Diaz E, Madgett TE, Storry JR, Beiboer S, Maaskant-van Wijk PM, von Zabern I, Jimenez E, Tejedor D, Lopez M, Camacho E, Cheroutre G, Hacker A, Jinoch P, Svobodova I, van der Schoot E, de Haas M: The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother 2009;36:162-167.
4.
Paris S, Rigal D, Barlet V, Verdier M, Coudurier N, Bailly P, Bres JC: Flexible automated platform for blood group genotyping on DNA microarrays. J Mol Diagn 2014;16:335-342.
5.
Lopez M, Apraiz I, Rubia M, Piedrabuena M, Azkarate M, Veldhuisen B, Vesga MA, Van Der Schoot E, Puente F, Tejedor D: Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform. Blood Transfus 2018;16:193-199.
6.
Hashmi G, Shariff T, Zhang Y, Cristobal J, Chau C, Seul M, Vissavajjhala P, Baldwin C, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Reid ME: Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007;47:736-747.
7.
Denomme GA, Van Oene M: High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005;45:660-666.
8.
Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M: High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006;46:841-848.
9.
Di Cristofaro J, Silvy M, Chiaroni J, Bailly P: Single PCR multiplex SNaPshot reaction for detection of eleven blood group nucleotide polymorphisms: optimization, validation, and one year of routine clinical use. J Mol Diagn 2010;12:453-460.
10.
Palacajornsuk P, Halter C, Isakova V, Tarnawski M, Farmar J, Reid ME, Chaudhuri A: Detection of blood group genes using multiplex SNaPshot method. Transfusion 2009;49:740-749.
11.
Meyer S, Vollmert C, Trost N, Bronnimann C, Gottschalk J, Buser A, Frey BM, Gassner C.:High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry-based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 2014;54:3198-3207.
12.
Silvy M, Di Cristofaro J, Beley S, Papa K, Rits M, Richard P, Chiaroni J, Bailly P: Identification of RHCE and KEL alleles in large cohorts of Afro-Caribbean and Comorian donors by multiplex SNaPshot and fragment assays: a transfusion support for sickle cell disease patients. Br J Haematol 2011;154:260-270.
13.
Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J Jr, Castilho L: DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009;97:147-152.
14.
Seltsam A, Wagner FF, Salama A, Flegel WA: Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003;43:1563-1566.
15.
Reesink HW, Engelfriet CP, Schennach H, Gassner C, Wendel S, Fontao-Wendel R, de Brito MA, Sistonen P, Matilainen J, Peyrard T, Pham BN, Rouger P, Le Pennec PY, Flegel WA, von Zabern I, Lin CK, Tsoi WC, Hoffer I, Barotine-Toth K, Joshi SR, Vasantha K, Yahalom V, Asher O, Levene C, Villa MA, Revelli N, Greppi N, Marconi M, Tani Y, Folman CC, de Haas M, Koopman MM, Beckers E, Gounder DS, Flanagan P, Wall L, Aranburu Urtasun E, Hustinx H, Niederhauser C, Flickinger C, Nance SJ, Meny GM: Donors with a rare pheno (geno) type. Vox Sang 2008;95:236-253.
16.
Flickinger C: In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology 2006;22:6.
17.
Wagner FF, Bittner R, Petershofen EK, Doescher A, Muller TH: Cost-efficient sequence-specific priming-polymerase chain reaction screening for blood donors with rare phenotypes. Transfusion 2008;48:1169-1173.
18.
Lee S, Naime DS, Reid ME, Redman CM.:Molecular basis for the high-incidence antigens of the Kell blood group system. Transfusion 1997;37:1117-1122.
19.
Moller M, Joud M, Storry JR, Olsson ML: Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240-249.
20.
Holm S: A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:5.
21.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG: Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016;536:285-291.
22.
Ji Y, Veldhuisen B, Ligthart P, Haer-Wigman L, Jongerius J, Boujnan M, Ait Soussan A, Luo G, Fu Y, van der Schoot CE, de Haas M: Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population. Transfusion 2015;55:413-421.
23.
Jungbauer C, Hobel CM, Schwartz DW, Mayr WR: High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang 2012;102:234-242.
24.
Ballif BA, Helias V, Peyrard T, Menanteau C, Saison C, Lucien N, Bourgouin S, Le Gall M, Cartron JP, Arnaud L: Disruption of SMIM1 causes the Vel- blood type. EMBO Mol Med 2013;5:751-761.
25.
He YL, Gao HH, Ye LY, Guo ZH, Wang P, Zhu ZY: Multiplex polymerase chain reaction with DNA pooling: a cost-effective strategy of genotyping rare blood types. Transfus Med 2013;23:42-47.
26.
Perreault J, Lavoie J, Painchaud P, Cote M, Constanzo-Yanez J, Cote R, Delage G, Gendron F, Dubuc S, Caron B, Lemieux R, St-Louis M: Set-up and routine use of a database of 10,555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients. Vox Sang 2009;97:61-68.
© 2018 S. Karger GmbH, Freiburg
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.